Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Prevalence Of Chronic Diseases
3.1.2. Health Practitioners Prefer Contrast Enhanced Ultrasound Imaging
3.1.3. Technological Advancements In Diagnosis
3.2. Key Restraints
3.2.1. Non-Uniformity Of Contrast Agents
3.2.2. Difficulty In Adoption In The Current Healthcare System

4. Key Analytics
4.1. Impact Of Covid-19 On Contrast Enhanced Ultrasound Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.7.1. Cost Efficiency
4.7.2. Product Features
4.7.3. End-Use
4.8. Regulatory Framework

5. Market By Product
5.1. Equipment
5.2. Contrast Agent

6. Market By Type
6.1. Non-Targeted
6.2. Targeted

7. Market By End-User
7.1. Hospitals
7.2. Clinics
7.3. Ambulatory Diagnostic Centers

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.2. Canada
8.2. Europe
8.2.1. Market Size & Estimates
8.2.2. Key Growth Enablers
8.2.3. Key Challenges
8.2.4. Key Players
8.2.5. Country Analysis
8.2.5.1. United Kingdom
8.2.5.2. Germany
8.2.5.3. France
8.2.5.4. Italy
8.2.5.5. Spain
8.2.5.6. Nordic Countries
8.2.5.7. Rest Of Europe
8.3. Asia-Pacific
8.3.1. Market Estimates & Sizes
8.3.2. Key Growth Enablers
8.3.3. Key Challenges
8.3.4. Key Players
8.3.5. Country Analysis
8.3.5.1. China
8.3.5.2. Japan
8.3.5.3. India
8.3.5.4. South Korea
8.3.5.5. Indonesia
8.3.5.6. Singapore
8.3.5.7. Taiwan
8.3.5.8. Australia & New Zealand
8.3.5.9. Rest Of Asia-Pacific
8.4. Rest Of World
8.4.1. Market Estimates & Sizes
8.4.2. Key Growth Enablers
8.4.3. Key Challenges
8.4.4. Key Players
8.4.5. Regional Analysis
8.4.5.1. Latin America
8.4.5.2. Middle East & Africa

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Bayer Ag
9.2.2. Bracco Diagnostic Inc
9.2.3. Daiichi Sankyo Company Limited
9.2.4. Ge Healthcare
9.2.5. Koninklijke Philips Nv
9.2.6. Lantheus Medical Imaging Inc
9.2.7. Nanopet Pharma Gmbh
9.2.8. Sanochemia Pharmazeutika Gmbh
9.2.9. Shenzhen Mindray Bio-Medical Electronics Co Ltd
9.2.10. Siemens Healthineers Ag
9.2.11. Taejoon Pharm
9.2.12. Trivitron Healthcare



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Value Chain Analysis
Figure 6: Key Buying Criteria
Figure 7: Global Contrast Enhanced Ultrasound Market, Growth Potential, By Product, In 2021
Figure 8: Global Contrast Enhanced Ultrasound Market, By Equipment, 2022-2030 (In $ Million)
Figure 9: Global Contrast Enhanced Ultrasound Market, By Contrast Agent, 2022-2030 (In $ Million)
Figure 10: Global Contrast Enhanced Ultrasound Market, Growth Potential, By Type, In 2021
Figure 11: Global Contrast Enhanced Ultrasound Market, By Non-Targeted, 2022-2030 (In $ Million)
Figure 12: Global Contrast Enhanced Ultrasound Market, By Targeted, 2022-2030 (In $ Million)
Figure 13: Global Contrast Enhanced Ultrasound Market, Growth Potential, By End-User, In 2021
Figure 14: Global Contrast Enhanced Ultrasound Market, By Hospitals, 2022-2030 (In $ Million)
Figure 15: Global Contrast Enhanced Ultrasound Market, By Clinics, 2022-2030 (In $ Million)
Figure 16: Global Contrast Enhanced Ultrasound Market, By Ambulatory Diagnostic Centers, 2022-2030 (In $ Million)
Figure 17: North America Contrast Enhanced Ultrasound Market, Country Outlook, 2021 & 2030 (In %)
Figure 18: United States Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 19: Canada Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 20: Europe Contrast Enhanced Ultrasound Market, Country Outlook, 2021 & 2030 (In %)
Figure 21: United Kingdom Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 22: Germany Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 23: France Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 24: Italy Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 25: Spain Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 26: Nordic Countries Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 27: Rest Of Europe Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 28: Asia-Pacific Contrast Enhanced Ultrasound Market, Country Outlook, 2021 & 2030 (In%)
Figure 29: China Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 30: Japan Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 31: India Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 32: South Korea Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 33: Indonesia Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 34: Singapore Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 35: Taiwan Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 36: Australia & New Zealand Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 37: Rest Of Asia-Pacific Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 38: Rest Of World Contrast Enhanced Ultrasound Market, Regional Outlook, 2021 & 2030 (In %)
Figure 39: Latin America Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)
Figure 40: Middle East & Africa Contrast Enhanced Ultrasound Market, 2022-2030 (In $ Million)

List of Tables

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING PREVALENCE OF CHRONIC DISEASES
3.1.2. HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
3.1.3. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
3.2. KEY RESTRAINTS
3.2.1. NON-UNIFORMITY OF CONTRAST AGENTS
3.2.2. DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
4.7.1. COST EFFICIENCY
4.7.2. PRODUCT FEATURES
4.7.3. END-USE
4.8. REGULATORY FRAMEWORK
5. MARKET BY PRODUCT
5.1. EQUIPMENT
5.2. CONTRAST AGENT
6. MARKET BY TYPE
6.1. NON-TARGETED
6.2. TARGETED
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS
7.3. AMBULATORY DIAGNOSTIC CENTERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. KEY GROWTH ENABLERS
8.2.3. KEY CHALLENGES
8.2.4. KEY PLAYERS
8.2.5. COUNTRY ANALYSIS
8.2.5.1. UNITED KINGDOM
8.2.5.2. GERMANY
8.2.5.3. FRANCE
8.2.5.4. ITALY
8.2.5.5. SPAIN
8.2.5.6. NORDIC COUNTRIES
8.2.5.7. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET ESTIMATES & SIZES
8.3.2. KEY GROWTH ENABLERS
8.3.3. KEY CHALLENGES
8.3.4. KEY PLAYERS
8.3.5. COUNTRY ANALYSIS
8.3.5.1. CHINA
8.3.5.2. JAPAN
8.3.5.3. INDIA
8.3.5.4. SOUTH KOREA
8.3.5.5. INDONESIA
8.3.5.6. SINGAPORE
8.3.5.7. TAIWAN
8.3.5.8. AUSTRALIA & NEW ZEALAND
8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
8.4.1. MARKET ESTIMATES & SIZES
8.4.2. KEY GROWTH ENABLERS
8.4.3. KEY CHALLENGES
8.4.4. KEY PLAYERS
8.4.5. REGIONAL ANALYSIS
8.4.5.1. LATIN AMERICA
8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. BAYER AG
9.2.2. BRACCO DIAGNOSTIC INC
9.2.3. DAIICHI SANKYO COMPANY LIMITED
9.2.4. GE HEALTHCARE
9.2.5. KONINKLIJKE PHILIPS NV
9.2.6. LANTHEUS MEDICAL IMAGING INC
9.2.7. NANOPET PHARMA GMBH
9.2.8. SANOCHEMIA PHARMAZEUTIKA GMBH
9.2.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
9.2.10. SIEMENS HEALTHINEERS AG
9.2.11. TAEJOON PHARM
9.2.12. TRIVITRON HEALTHCARE





List of Tables

TABLE 1: GLOBAL MARKET SNAPSHOT – CONTRAST ENHANCED ULTRASOUND
TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS
TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: GLOBAL EQUIPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: GLOBAL EQUIPMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: GLOBAL CONTRAST AGENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: GLOBAL CONTRAST AGENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: GLOBAL NON-TARGETED MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: GLOBAL NON-TARGETED MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: GLOBAL TARGETED MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: GLOBAL TARGETED MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: GLOBAL CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: GLOBAL CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: GLOBAL AMBULATORY DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: GLOBAL AMBULATORY DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: LEADING PLAYERS OPERATING IN NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET
TABLE 30: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 31: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 32: LEADING PLAYERS OPERATING IN EUROPE CONTRAST ENHANCED ULTRASOUND MARKET
TABLE 33: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET
TABLE 36: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 37: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 38: LEADING PLAYERS OPERATING IN REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET
TABLE 39: LIST OF MERGERS & ACQUISITIONS
TABLE 40: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 41: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 42: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
List of Figures
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 8: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)
FIGURE 9: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 11: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)
FIGURE 12: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)
FIGURE 13: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 14: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)
FIGURE 16: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)
FIGURE 17: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 18: UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 19: CANADA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 20: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 21: UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: GERMANY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 23: FRANCE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: ITALY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 25: SPAIN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 26: NORDIC COUNTRIES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: REST OF EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
FIGURE 29: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 39: LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)